Mat leads technology acquisitions and investments in startup companies that align with Corteva’s strategic priorities. He has a passion for collaboration tactics which allow the company to deliver industry-leading traits in must-win battlegrounds. Prior to this role, Mat led Corteva’s Biotechnology Strategy function, established and developed Corteva’s Open Innovation platform, and led the company’s CRISPR licensing strategies. He has held leadership positions in science and business at DuPont, Pioneer Hi-Bred, Verdia and Maxygen. Mat’s education includes a Ph.D. in Biology from the University of Lausanne, and an MBA from California State University at Hayward.